COVID-19: Toxicities of Potential Therapies

May 13, 2020 • 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

September 11, 2018 • 00:24:03
Episode Cover

Bicarbonate for Severe Acidosis?

Many critically ill patients are acidotic.  Often, bicarbonate is administered to severely acidotic patients, but does it really improve outcomes?  The BICAR-ICU was just...

Listen

Episode

May 23, 2026 • 00:32:12
Episode Cover

High-Flow or Standard O2 for Hypoxemic Respiratory Failure?

Acute hypoxemic respiratory failure is a leading cause of ICU admission worldwide.  Oxygen is first-line therapy for patients with acute hypoxemic respiratory failure and...

Listen

Episode

January 27, 2017 • 00:24:56
Episode Cover

The Complicated Alcohol Withdrawal Patient

Bryan Hayes is back!  In this podcast, we discuss pitfalls in the use of benzodiazpines along with current evidence on adjunctive treatments including propofol,...

Listen